SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-012532
Filing Date
2023-08-23
Accepted
2023-08-23 13:09:47
Documents
1
Period of Report
2023-08-21

Document Format Files

Seq Description Document Type Size
1 form4-08232023_050842.html 4  
1 form4-08232023_050842.xml 4 4345
  Complete submission text file 0001415889-23-012532.txt   5926
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Anderson Cynthia Lynn (Reporting) CIK: 0001989905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 231196512